(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 1. Fgf9, FGFR1 and FGFR2 expression in the embryonic cecum.
(A,B) Whole-mount in situ hybridization was performed on isolated E11.5
(A) and E13.5 (B) wild-type GI tracts to detect Fgf9 expression.
Insets show small intestine and colon. Fgf9 expression was uniformly
expressed in the epithelium of the cecum, small intestine and colon.
(C) Frozen section of an E13.5 whole-mount in situ hybridization
showing Fgf9 expression in the cecal epithelium (arrows).
(D-F) Immunohistochemical analysis of E12.5 cecal sections stained with
an anti-FGFR1 (E) or anti-FGFR2 (F) polyclonal antibody. Control (D) staining,
in which the primary antibody was absent, shows no signal.
D',E' and F' are higher magnification
views of the boxes in D,E and F, respectively. FGFR1 (E') and FGFR2
(F') are expressed in both cecal epithelium (black arrows) and
mesenchyme (blue arrows). Co, colon; I, Ileum; SI, small intestine; Ce,
cecum.